Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.
Whole-body cryotherapy (WBC) significantly reduced pain and disease activity in people with fibromyalgia; and that result likely was due to alterations to levels of immune signaling proteins called cytokines, a ... Read more
A non-opioid therapy called ASP0819 failed to reduce fibromyalgia-associated pain over eight weeks, but showed promise as a safe treatment for sleep problems in a Phase 2a trial. The findings ... Read more
In women with fibromyalgia with ingrained perfectionism, avoiding activities in anticipation of pain negatively impacts functionality. But conversely, persisting in activities to complete tasks has positive effects, a study finds. ... Read more
The combination of Lyrica (pregabalin) and Savella (milnacipran) is not more effective than pregabalin alone in treating women with fibromyalgia, a study found. The study, “Efficacy of pregabalin as a ... Read more
Canntab Therapeutics will participate in a five-year study of cannabis-based therapies to treat fibromyalgia and other disorders that are unresponsive to treatment. The Canadian company also is launching a suite ... Read more
Enrollment has resumed for Aptinyx‘s Phase 2 clinical trial of NYX-2925, an oral small molecule designed to treat chronic pain in adults with fibromyalgia, the company announced. The study (NCT04147858) is ... Read more
Moist, tropical weather types are linked to an increase in emergency department (ED) visits for people with fibromyalgia and other pain-inducing disorders, a study found. The seven-year analysis of patient ... Read more